Share on StockTwits

TherapeuticsMD (NASDAQ:TXMD) announced its earnings results on Monday. The company reported ($0.06) earnings per share (EPS) for the quarter, meeting the consensus estimate of ($0.06), StockRatingsNetwork reports. During the same quarter in the previous year, the company posted ($0.06) earnings per share.

On the ratings front, analysts at Noble Financial raised their price target on shares of TherapeuticsMD from $9.00 to $13.00 in a research note on Thursday, April 17th. They now have a “buy” rating on the stock.

Shares of TherapeuticsMD (NASDAQ:TXMD) traded down 1.00% during mid-day trading on Monday, hitting $3.97. The stock had a trading volume of 819,369 shares. TherapeuticsMD has a one year low of $2.03 and a one year high of $9.01. The stock has a 50-day moving average of $5.49 and a 200-day moving average of $5.37. The company’s market cap is $575.7 million.

TherapeuticsMD, Inc is a women’s healthcare company focused on developing and commercializing products targeted exclusively for women.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.